Back to Archived Journals » Botanics: Targets and Therapy » Volume 6

Remission roles of the herbal formula B401 in mice with manganese-induced neurotoxicity
Authors Hsu C, Wang S, Lin C, Sheu S, Wu C
Received 16 March 2016
Accepted for publication 7 June 2016
Published 25 August 2016 Volume 2016:6 Pages 75—88
DOI https://doi.org/10.2147/BTAT.S108648
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Ayse Kuruuzum-Uz
Chih-Hsiang Hsu,1 Sheue-Er Wang,2 Ching-Lung Lin,1 Shuenn-Jyi Sheu,3 Chung-Hsin Wu1
1Department of Life Sciences, National Taiwan Normal University, Taipei City, 2Department of Pathological Inspection, Saint Paul’s Hospital, Taoyuan City, 3Brion Research Institute of Taiwan, New Taipei City, Taiwan
Abstract: Excessive exposure to manganese (Mn), mainly by occupational inhalation, may cause brain and motor defects that are known as manganism. There are a few pharmacological studies aimed at treating the symptoms of manganism. The herbal formula B401 may serve as a new lead in ameliorating Mn-induced neurotoxicity. In this study, we aimed to investigate the possible protective mechanisms of the herbal formula B401 against Mn-induced neurotoxicity. Thirty-two ICR mice were divided into four groups that were administered sham treatment, B401 treatment, Mn treatment, and B401 plus Mn treatment, respectively (n=8 for each group). Rotarod performance was used in these mice to compare their motor coordination. In addition, chemiluminescence analysis was used to examine the reactive oxygen species in their blood. Furthermore, immunostaining and Western blotting techniques were used to examine the expression of dopaminergic receptors, dopamine, brain-derived neurotrophic factor (BDNF), and oxidative stress and apoptosis-related protein markers in their brain tissue. We found that the mice given Mn treatment showed brain and motor defects in comparison to the mice undergoing sham treatment. Immunostaining and Western blotting revealed that the mice given Mn treatment had reduced dopaminergic and BDNF expressions, but enhanced oxidative stress and apoptosis-related protein markers in their brain tissue. While the mice administered B401 plus Mn treatment had significantly improved motor coordination and enhanced dopaminergic and BDNF expressions, they showed reduced oxidative stress and apoptosis-related protein markers in their brain tissue in comparison with the mice given Mn treatment. Our findings provide evidence that oral B401 treatment may alleviate the symptoms of Mn-induced neurotoxicity in mice by enhancing dopaminergic and BDNF expressions and suppressing oxidative stress and apoptosis in their brain tissue. Therefore, we suggest that the herbal formula B401 may be developed as a potential health supplement for ameliorating Mn-induced neurotoxicity.
Keywords: manganism, neurodegeneration, motor disorder, dopaminergic receptor, dopamine, brain-derived neurotrophic
factor, oxidative stress, apoptosis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.